A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 266 participants.
Also called NCT07904507
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 266 participants
- Sponsor
- Registry
-
NCT07904507
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Switzerland
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07904507. Randomized; triple masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2029-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation
- Acronym
- BRACE-AFib
- Condition
- Atrial Fibrillation (AF)
- Intervention (Drug)
- Diltiazem
- Intervention (Drug)
- Bisoprolol
- Lead sponsor
- University Hospital, Basel, Switzerland
- Collaborator
- Swiss National Science Foundation
- Collaborator
- Schweizerische Herzstiftung
- Collaborator
- Freiwillige Akademische Gesellschaft Basel
- Collaborator
- Clinical Trial Unit, University Hospital Basel, Switzerland
Record details
- Record id
cardio:ct-nct07904507- Content hash
3116cd98648801f76d2039a1dc02ed83bab3b0d1cd691e6ac821ea68dfebab3b